Talk to your doctor. Ask about AMITIZA.
Full Prescribing Information Important Safety Information For Healthcare Providers Other Takeda Products
SHARE WITH A FRIENDibs with constipation \ already taking AMITIZA \ sticking to your AMITIZA treatment

Sticking to Your AMITIZA Treatment

Sticking to Your Treatment

You've taken the all-important step of discussing your IBS with Constipation (IBS-C) with your healthcare provider and you've received a prescription for AMITIZA. That's great. But your relationship with your healthcare professional doesn't stop there.

Because IBS-C is a medical condition, you will need to stick to your treatments, monitor your progress, and regularly share that information with your healthcare provider.

Here are some tips for sticking to your treatments.

  • It all starts with filling the prescription. You may be eligible for the AMITIZA Healthy Savings Program
  • Take AMITIZA as directed by your healthcare provider. For IBS-C, the dose is one pink 8 mcg gelcap taken twice a day with food and water. Swallow the gelatin capsule whole. Do not break it apart and do not chew it. Tell your doctor if you have liver problems.
  • Chart your progress. You documented your symptoms in the past. Now, use the AMITIZA Progress Checker to track how you are doing on AMITIZA.
  • Make sure to write down any additional questions you may have. Bring this information, along with a notebook and pen, to your next appointment.
  • Schedule a follow-up appointment with your healthcare provider.

§You must meet Eligibility Requirements.

This Progress Checker identifies key symptoms of your condition, and helps you keep track of them over a six-week period.

Indication

AMITIZA (8 mcg) twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women 18 years of age and older.

Important Safety Information

AMITIZA is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider should evaluate your condition before starting AMITIZA. You should not take AMITIZA if you have severe diarrhea.

AMITIZA has not been studied in pregnant women and should only be used during a pregnancy if the potential benefits justify the potential risk to the fetus. Women should have a negative pregnancy test before beginning treatment with AMITIZA and need to practice effective birth control measures. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your healthcare provider to evaluate the risks to the fetus.

Some patients taking AMITIZA may experience nausea or diarrhea. If nausea occurs, take AMITIZA with food. If your nausea or diarrhea becomes severe, tell your healthcare provider.

Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your healthcare provider if you experience these symptoms.

The most common side effects of taking AMITIZA (8 mcg) twice daily, pink capsules for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.

Tell your doctor if you have liver problems.

Please click here for complete Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.


This site is intended for use by U.S. residents only.

1-888-9-AMITIZA

AMITIZA is a trademark of Sucampo Pharmaceuticals, Inc. registered with the U.S. Patent and Trademark Office and used under license by Takeda Pharmaceuticals America, Inc.

©2012 Takeda Pharmaceuticals U.S.A., Inc.